These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 28553325)

  • 1. Neurotrophic factors in Alzheimer's and Parkinson's diseases: implications for pathogenesis and therapy.
    Sampaio TB; Savall AS; Gutierrez MEZ; Pinton S
    Neural Regen Res; 2017 Apr; 12(4):549-557. PubMed ID: 28553325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Neurotrophic factors: basis for their clinical application].
    Morís G; Vega JA
    Neurologia; 2003; 18(1):18-28. PubMed ID: 12590377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotrophins and glial cell line-derived neurotrophic factor in the ovary: physiological and pathophysiological implications.
    Chang HM; Wu HC; Sun ZG; Lian F; Leung PCK
    Hum Reprod Update; 2019 Mar; 25(2):224-242. PubMed ID: 30608586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel neurotrophic factor CDNF protects and rescues midbrain dopamine neurons in vivo.
    Lindholm P; Voutilainen MH; Laurén J; Peränen J; Leppänen VM; Andressoo JO; Lindahl M; Janhunen S; Kalkkinen N; Timmusk T; Tuominen RK; Saarma M
    Nature; 2007 Jul; 448(7149):73-7. PubMed ID: 17611540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GDNF, NGF and BDNF as therapeutic options for neurodegeneration.
    Allen SJ; Watson JJ; Shoemark DK; Barua NU; Patel NK
    Pharmacol Ther; 2013 May; 138(2):155-75. PubMed ID: 23348013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Neurotrophic Factors in Glial Cells in the Central Nervous System: Expression and Properties in Neurodegeneration and Injury.
    Pöyhönen S; Er S; Domanskyi A; Airavaara M
    Front Physiol; 2019; 10():486. PubMed ID: 31105589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GDNF fails to exert neuroprotection in a rat α-synuclein model of Parkinson's disease.
    Decressac M; Ulusoy A; Mattsson B; Georgievska B; Romero-Ramos M; Kirik D; Björklund A
    Brain; 2011 Aug; 134(Pt 8):2302-11. PubMed ID: 21712347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neurotrophin family of NGF-related neurotrophic factors.
    Lindsay RM; Alderson RF; Friedman B; Hyman C; Ip NY; Furth ME; Maisonpierre PC; Squinto SP; Yancopoulos GD
    Restor Neurol Neurosci; 1991 Jan; 2(4):211-20. PubMed ID: 21551605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotrophic factors in neurodegenerative disorders: model of Parkinson's disease.
    Garcia de Yebenes J; Yebenes J; Mena MA
    Neurotox Res; 2000; 2(2-3):115-37. PubMed ID: 16787836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neural stem cells express melatonin receptors and neurotrophic factors: colocalization of the MT1 receptor with neuronal and glial markers.
    Niles LP; Armstrong KJ; Rincón Castro LM; Dao CV; Sharma R; McMillan CR; Doering LC; Kirkham DL
    BMC Neurosci; 2004 Oct; 5():41. PubMed ID: 15511288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenoviral vector-mediated delivery of glial cell line-derived neurotrophic factor provides neuroprotection in the aged parkinsonian rat.
    Connor B
    Clin Exp Pharmacol Physiol; 2001 Nov; 28(11):896-900. PubMed ID: 11703392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of the endoplasmic reticulum located and secreted CDNF/MANF family of neurotrophic factors in Parkinson's disease.
    Voutilainen MH; Arumäe U; Airavaara M; Saarma M
    FEBS Lett; 2015 Dec; 589(24 Pt A):3739-48. PubMed ID: 26450777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effects of NGF, BDNF, NT-3 and GDNF on axotomized extraocular motoneurons in neonatal rats.
    Morcuende S; Muñoz-Hernández R; Benítez-Temiño B; Pastor AM; de la Cruz RR
    Neuroscience; 2013 Oct; 250():31-48. PubMed ID: 23827308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor are required simultaneously for survival of dopaminergic primary sensory neurons in vivo.
    Erickson JT; Brosenitsch TA; Katz DM
    J Neurosci; 2001 Jan; 21(2):581-9. PubMed ID: 11160437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDNF Protein Therapy in Parkinson's Disease.
    Huttunen HJ; Saarma M
    Cell Transplant; 2019 Apr; 28(4):349-366. PubMed ID: 30947516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Possible relation of BDNF and GDNF to neuropsychiatric disorders].
    Hibi Y; Nitta A; Nabeshima T; Yamada K
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2009 Apr; 29(2):85-9. PubMed ID: 19562947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for an Additive Neurorestorative Effect of Simultaneously Administered CDNF and GDNF in Hemiparkinsonian Rats: Implications for Different Mechanism of Action.
    Voutilainen MH; De Lorenzo F; Stepanova P; Bäck S; Yu LY; Lindholm P; Pörsti E; Saarma M; Männistö PT; Tuominen RK
    eNeuro; 2017; 4(1):. PubMed ID: 28303260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoamine oxidase inhibitors as neuroprotective agents in age-dependent neurodegenerative disorders.
    Naoi M; Maruyama W
    Curr Pharm Des; 2010; 16(25):2799-817. PubMed ID: 20698822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotrophic Factors in Parkinson's Disease: Clinical Trials, Open Challenges and Nanoparticle-Mediated Delivery to the Brain.
    Bondarenko O; Saarma M
    Front Cell Neurosci; 2021; 15():682597. PubMed ID: 34149364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Signaling Pathway of Neurotrophic Factor Biosynthesis.
    Obara Y; Nakahata N
    Drug News Perspect; 2002 Jun; 15(5):290-298. PubMed ID: 12677225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.